4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-056844
Director sold 65,431 shares at an average $65.22 ($4,267,494)
- Director acquired 65,431 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MCGIRR DAVID W J Director | 2025-06-03 | Option exercise 10b5-1 | +65,431 | $4.59 | $300,328 | 68,431 | D |
| MCGIRR DAVID W J Director | 2025-06-03 | Sale 10b5-1 | −55,558 | $65.15 | $3,619,404 | 12,873 | D |
| MCGIRR DAVID W J Director | 2025-06-03 | Sale 10b5-1 | −9,873 | $65.64 | $648,090 | 3,000 | D |
| Derivatives | |||||||
| MCGIRR DAVID W J Director | 2025-06-03 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −65,431 | 0 | D | ||
| Open-market sales · 65,431 sh · avg $65.22 · $4,267,494 | |||||||
Loading xslF345X05/tm2517215-2_4seq1.xml…